2-Hydrazino-4,7-dimethoxy-1,3-benzothiazole, 95.0%, 500mg

2-Amino-4,5-dimethyl-1-(2,4,6-trimethyl-phenyl)-1H-pyrrole-3-carbonitrile, 95.0%, 500mg

4-Nitrophenyl-a-L-rhamnoside, 95.0%, 1g

tert-Butyl-4-aminophenylacetate, 98.0%, 10g

tert-Butyl 4-(3-methoxy-3-oxopropyl)piperazine-1-carboxylate, 95%, 250mg

1,26-Dibromo-3,6,9,12,15,18,21,24-octaoxahexacosane, 98%, 500mg

4-Cyano-4'-(trans-4-pentylcyclohexyl)-biphenyl, 98.0%, 5g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 150, 5000 ml, 250 mm, 1 pieza

1-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4-CARBOXYLIC ACID, 95.0%, 500mg

2-(2,5-Dimethyl-1H-pyrrol-1-yl)-5-methoxypyridine, 95.0%, 1g

Fmoc-Val-Cit-PAB-PNP>95.0%(HPLC)100mg

6-Fluoro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

ETHYL MALONYL HYDRAZIDE, 97.0%, 5g